The next step in precision medicine lies in decentralizing comprehensive biomarker testing Envisioned to drive a new standard of cancer care, HealthCare Global Enterprises Limited (HCG Cancer Hospital Bengaluru) and Strand Life Sciences launched comprehensive genomic profiling (CGP), an approach to detect multiple actionable cancer biomarkers at ‘one
Biocon Limited (BSE: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company, announced today that Anupam Jindal has been appointed as the company’s new Chief Financial Officer (CFO). Anupam will head the finance function at Biocon and be part of the Executive Leadership Team. He will
Focuses on AI in Histopathology with emphasis on Breast Cancer Continuing with its transformative efforts in the field of Artificial Intelligence in Pathology, SRL Diagnostics, today announced the second phase of their AI solution development engagement with a technology and data science grant from Microsoft’s AI
In a case that provides hope for the treatment of patients suffering from covid19, medical specialists at Aster CMI Hospital successfully revived and gave a 51-year-old Covid-19 patient, Sahiba (name changed) a new lease of life after she suffered from three consecutive cardiac arrests within
The team has shown results in treating Rabbits & is exploring funding opportunities for applications in Humans as Magnesium is the 4th abundant metal in the body and is known to accelerate the healing of bones Indian Institute of Technology Madras Researchers have developed nano-coated magnesium alloys
The eminent panellists present were Dr. Anil Khurana, Director General, Central Council for Research in Homoeopathy, Dr. R. K. Manchanda, Director AYUSH, Govt. of NCT. of Delhi, Mr. Arvind Varchaswi, Chairman, AYUSH Committee, Mr. Vivek Seigell, Principal Director, PHDCCI, Dr. R.N. Wahi, Chairman, Organising Committee,
· India’s first CRISPR Covid-19 test, developed by the Tata Group and CSIR-IGIB, has been approved for use in India. The Tata CRISPR test, powered by CSIR-IGIB FELUDA, received regulatory approvals today from the Drug Controller General of India (DCGI) for commercial launch, as per ICMR guidelines, meeting
Niramai Health Analytix, India’s foremost and innovative AI-based breast cancer screening company has tied-up with Apollo Clinic, India’s leading multi-specialty clinics by Apollo Health & Lifestyle (AHLL), to offer contact-less, privacy-sensitive, breast cancer screening services to customers. The screening services will be initially available at
3 months old baby with severe Congenital Heart Defects (CHD) travelled through road in three states before getting treatment A team of doctors at Fortis Escorts Heart Institute (FEHI) at Okhla in Delhi worked tirelessly to transport, treat & save the life of a 3 months old baby
Unlike the conventional pacemaker, this advanced technology helps in giving access to critical information anytime, anywhere. This novel pacemaker is a breakthrough concept as it allows remote monitoring which has proven to be resulting in higher survival rates In a first in India, doctors at
